Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Morrison

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Translational Stroke Research|April 17, 2015
Acute Multi-modal Neuroimaging in a Porcine Model of Endothelin-1-Induced Cerebral Ischemia: Defining the Acute Infarct CoreChristopher D d'Esterre, Richard I Aviv, Laura Morrison, et al.
Current Medical Research and Opinion|January 28, 2020
Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depressionDominic Pilon, Holly Szukis, David Singer, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 25, 2018
Device-assisted tensioning is associated with lower rates of graft failure when compared to manual tensioning in ACL reconstructionLaura Morrison, Chloe Haldane, Darren de Sa, et al.
Schizophrenia Research|August 15, 2017
Disengagement in immigrant groups receiving services for a first episode of psychosisAnika Maraj, Franz Veru, Laura Morrison, et al.
Dermatology and Therapy|March 19, 2022
Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USADominic Pilon, Timothy Fitzgerald, Maryia Zhdanava, et al.
Journal of Managed Care & Specialty Pharmacy|November 10, 2022
Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitateLaura Morrison, Dee Lin, Carmela Benson, et al.
Journal of Affective Disorders|May 26, 2019
Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?Dominic Pilon, John J Sheehan, Holly Szukis, et al.
Biomedical Optics Express|October 1, 2019
Development of a stand-alone DCS system for monitoring absolute cerebral blood flowMahro Khalid, Daniel Milej, Ajay Rajaram, et al.
Clinical Therapeutics|February 16, 2021
Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia RelapseMaryia Zhdanava, Dee Lin, Marie-Hélène Lafeuille, et al.
Current Medical Research and Opinion|July 18, 2023
Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stayCharmi Patel, Dominic Pilon, Laura Morrison, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Translational Stroke Research|April 17, 2015
Acute Multi-modal Neuroimaging in a Porcine Model of Endothelin-1-Induced Cerebral Ischemia: Defining the Acute Infarct CoreChristopher D d'Esterre, Richard I Aviv, Laura Morrison, et al.
Current Medical Research and Opinion|January 28, 2020
Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depressionDominic Pilon, Holly Szukis, David Singer, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 25, 2018
Device-assisted tensioning is associated with lower rates of graft failure when compared to manual tensioning in ACL reconstructionLaura Morrison, Chloe Haldane, Darren de Sa, et al.
Schizophrenia Research|August 15, 2017
Disengagement in immigrant groups receiving services for a first episode of psychosisAnika Maraj, Franz Veru, Laura Morrison, et al.
Dermatology and Therapy|March 19, 2022
Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USADominic Pilon, Timothy Fitzgerald, Maryia Zhdanava, et al.
Journal of Managed Care & Specialty Pharmacy|November 10, 2022
Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitateLaura Morrison, Dee Lin, Carmela Benson, et al.
Journal of Affective Disorders|May 26, 2019
Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?Dominic Pilon, John J Sheehan, Holly Szukis, et al.
Biomedical Optics Express|October 1, 2019
Development of a stand-alone DCS system for monitoring absolute cerebral blood flowMahro Khalid, Daniel Milej, Ajay Rajaram, et al.
Clinical Therapeutics|February 16, 2021
Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia RelapseMaryia Zhdanava, Dee Lin, Marie-Hélène Lafeuille, et al.
Current Medical Research and Opinion|July 18, 2023
Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stayCharmi Patel, Dominic Pilon, Laura Morrison, et al.
Pageof 9